These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 6240401
21. [Basic and clinical studies on bone deposition of 99mTc-labeled hydroxymethylene diphosphonate: a comparison with 99mTc-methylene diphosphonate (author's transl)]. Muranaka A, Ito Y, Otsuka N, Nagai K, Terashima H, Yanagimoto S, Kaji T, Nakano Y, Hayashi M, Hazue M. Kaku Igaku; 1981 Mar; 18(2):273-81. PubMed ID: 6454802 [No Abstract] [Full Text] [Related]
22. [A solitary metastasis in the trapezium bone]. Lederer A, Flückiger F, Wildling R, Fruhwirth J. Radiologe; 1990 Feb; 30(2):79-80. PubMed ID: 2320730 [Abstract] [Full Text] [Related]
23. [Bone scintigraphy with 99mTc-hydroxymethylene diphosphonate (HMDP)--comparison with 99mtc-MDP (author's transl)]. Nakano S, Hasegawa Y, Shiomura K, Ibuka K, Hashizume T. Kaku Igaku; 1981 Dec; 18(10):1485-8. PubMed ID: 6210789 [No Abstract] [Full Text] [Related]
24. 99mTc-methylene diphosphonate lung uptake in mixed small and large cell lymphoma. Wynchank S. Eur J Nucl Med; 1982 Dec; 7(1):47-8. PubMed ID: 6460629 [No Abstract] [Full Text] [Related]
25. A comparison between the diagnostic efficacy of 99mTc-MDP, 99mTc-DPD and 99mTc-HDP for the detection of bone metastases. Pauwels EK, Blom J, Camps JA, Hermans J, Rijke AM. Eur J Nucl Med; 1983 Dec; 8(3):118-22. PubMed ID: 6220908 [Abstract] [Full Text] [Related]
27. Quantitative bone scan and bone metastases in prostatic cancer. Grob JC, Thiel J, Méthlin G, Wolf P, Bollack C. Urol Int; 1985 Dec; 40(1):45-7. PubMed ID: 3156441 [Abstract] [Full Text] [Related]
28. Serial radionuclide imaging during treatment of patients with diffuse bone metastases from carcinoma of the prostate. Perkins AC, Hardy JG, Wastie ML, Clifford KM. Eur J Nucl Med; 1982 Dec; 7(7):322-3. PubMed ID: 6214398 [No Abstract] [Full Text] [Related]
29. Technetium-99m-labeled methylene diphosphonate and hydroxyethylidine diphosphonate--biologic and clinical comparison: concise communication. Rudd TG, Allen DR, Smith FD. J Nucl Med; 1979 Aug; 20(8):821-6. PubMed ID: 120422 [Abstract] [Full Text] [Related]
30. Nuclear bone imaging in metastatic cancer of the prostate. Pollen JJ, Gerber K, Ashburn WL, Schmidt JD. Cancer; 1981 Jun 01; 47(11):2585-94. PubMed ID: 6266636 [No Abstract] [Full Text] [Related]
31. Accumulation of bone-scanning agents in hepatoma. Desai AG, Schaffer B, Park CH. Radiology; 1983 Oct 01; 149(1):292. PubMed ID: 6310684 [Abstract] [Full Text] [Related]
32. The bone scan as a tumour marker in prostatic carcinoma. Chisholm GD, Stone AR, Beynon LL, Merrick MV. Eur Urol; 1982 Oct 01; 8(5):257-60. PubMed ID: 6288389 [Abstract] [Full Text] [Related]
33. Focal lung uptake of technetium 99m methylene diphosphonate associated with pulmonary emboli and hypercalcaemia. Wraight EP. Br J Radiol; 1983 May 01; 56(665):345-7. PubMed ID: 6221773 [No Abstract] [Full Text] [Related]
37. Expanded 99mTc-methylene diphosphonate (MDP) bone scan. Pollen JJ, Witztum K, Basarab R. Urology; 1984 Dec 01; 24(6):632-8. PubMed ID: 6239440 [Abstract] [Full Text] [Related]
38. Relative lesion detection ability of Tc-99m HMDP and Tc-99m MDP: concise communication. Van Duzee BF, Schaefer JA, Ball JD, Chilton HM, Cowan RJ, Kuni C, Trow R, Watson NE. J Nucl Med; 1984 Feb 01; 25(2):166-9. PubMed ID: 6233404 [Abstract] [Full Text] [Related]
39. 99mTc-hydroxymethane diphosphonate: a new bone imaging agent with a low tin content. Domstad PA, Coupal JJ, Kim EE, Blake JS, DeLand FH. Radiology; 1980 Jul 01; 136(1):209-11. PubMed ID: 6446106 [Abstract] [Full Text] [Related]
40. Scintigraphic evaluation of primary bone tumors. Comparison of technetium-99m phosphonate and gallium citrate imaging. Simon MA, Kirchner PT. J Bone Joint Surg Am; 1980 Jul 01; 62(5):758-64. PubMed ID: 6446566 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]